Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,652Revenue $M3,377Net Margin (%)10.4Altman Z-Score3.9
Enterprise Value $M14,954EPS $4.5Operating Margin %24.9Piotroski F-Score6
P/E(ttm)43.7Beneish M-Score-2.9Pre-tax Margin (%)17.7Higher ROA y-yN
Price/Book8.910-y EBITDA Growth Rate %11.2Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %8.5Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow20.0y-y EBITDA Growth Rate %-43.2ROA % (ttm)6.9Higher Current Ratio y-yN
Dividend Yield %0.5PEG4.9ROE % (ttm)20.1Less Shares Outstanding y-yY
Payout Ratio %19.0Shares Outstanding M74.2ROIC % (ttm)12.4Gross Margin Increase y-yY

Gurus Latest Trades with BCR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRYacktman Focused Fund 2015-06-30 Reduce-0.54%$165.24 - $176.25
($170.8)
$ 197.4716%Reduce 22.13%950,000
BCRDonald Yacktman 2015-06-30 Reduce-0.43%$165.24 - $176.25
($170.8)
$ 197.4716%Reduce 16.64%2,773,248
BCRYacktman Fund 2015-06-30 Reduce-0.34%$165.24 - $176.25
($170.8)
$ 197.4716%Reduce 14.01%1,350,000
BCRJoel Greenblatt 2015-06-30 Sold Out -0.06%$165.24 - $176.25
($170.8)
$ 197.4716%Sold Out0
BCRDonald Yacktman 2015-03-31 Reduce-0.79%$164.52 - $178.59
($171.43)
$ 197.4715%Reduce 25.34%3,326,670
BCRYacktman Fund 2015-03-31 Reduce-0.75%$164.52 - $178.59
($171.43)
$ 197.4715%Reduce 25.10%1,570,000
BCRYacktman Focused Fund 2015-03-31 Reduce-0.71%$164.52 - $178.59
($171.43)
$ 197.4715%Reduce 24.41%1,220,000
BCRJoel Greenblatt 2015-03-31 Add0.04%$164.52 - $178.59
($171.43)
$ 197.4715%Add 213.81%44,492
BCRYacktman Fund 2014-12-31 Reduce-1.42%$144.77 - $172.68
($161.89)
$ 197.4722%Reduce 35.51%2,096,000
BCRDonald Yacktman 2014-12-31 Reduce-1.17%$144.77 - $172.68
($161.89)
$ 197.4722%Reduce 30.85%4,455,796
BCRYacktman Focused Fund 2014-12-31 Reduce-0.82%$144.77 - $172.68
($161.89)
$ 197.4722%Reduce 24.93%1,614,000
BCRRobert Olstein 2014-12-31 Sold Out -0.63%$144.77 - $172.68
($161.89)
$ 197.4722%Sold Out0
BCRJoel Greenblatt 2014-12-31 Reduce-0.31%$144.77 - $172.68
($162.11)
$ 197.4722%Reduce 93.82%14,178
BCRVanguard Health Care Fund 2014-12-31 Reduce-0.05%$144.77 - $172.68
($161.99)
$ 197.4722%Reduce 12.16%912,700
BCRJoel Greenblatt 2014-09-30 Add0.27%$142.3 - $153.13
($147.81)
$ 197.4734%Add 470.83%229,325
BCRYacktman Focused Fund 2014-09-30 Reduce-0.22%$142.3 - $153.13
($147.81)
$ 197.4734%Reduce 6.52%2,150,000
BCRDonald Yacktman 2014-09-30 Reduce-0.15%$142.3 - $153.13
($147.81)
$ 197.4734%Reduce 3.85%6,443,334
BCRYacktman Fund 2014-09-30 Reduce-0.1%$142.3 - $153.13
($147.7)
$ 197.4734%Reduce 2.40%3,250,000
BCRRobert Olstein 2014-09-30 Reduce-0.08%$142.3 - $153.13
($147.7)
$ 197.4734%Reduce 10.53%34,000
BCRVanguard Health Care Fund 2014-09-30 Reduce-0.04%$142.3 - $153.13
($147.7)
$ 197.4734%Reduce 10.22%1,039,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BCR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Luboff Sharon MGroup Vice President 2015-08-18Sell2,374$199.76-1.15view
Luboff Sharon MGroup Vice President 2015-08-17Sell2,030$200-1.27view
Thompson Tommy GDirector 2015-08-14Sell1,200$199.25-0.89view
Groetelaars John PGroup President 2015-08-07Sell9,416$196.680.4view
Christian Patricia GVP -Quality, Reg & Med Affairs 2015-08-05Sell2,093$199.16-0.85view
Collins Timothy PGroup President 2015-08-05Sell25,967$199.76-1.15view
DeFord John ASr. VP Sci Tech and Clin Afrs 2015-08-04Sell13,485$197.75-0.14view
Luboff Sharon MGroup Vice President 2015-08-03Sell5,000$195.990.76view
Lupisella Frank JrVice President and Controller 2015-07-31Sell2,685$1960.75view
RING TIMOTHY MChairman and CEO 2015-07-29Sell40,000$193.631.98view

Quarterly/Annual Reports about BCR:

News about BCR:

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA Jul 28 2015 
Medtronic Inc. (MDT) Dividend Stock Analysis Feb 25 2015 
Reversing a Declining Pattern in Earnings Per Share Feb 24 2015 
Teleflex Declares Its Quarter Four Results Feb 24 2015 
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis Nov 19 2014 
Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR Nov 09 2014 
Dividend Aristocrats In Focus Part 19 of 54: CR Bard Oct 15 2014 
Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
No More a Simple Distributor Sep 07 2014 

More From Other Websites
C.R. Bard, Inc. (New Jersey) Earnings Q2, 2015 Aug 28 2015
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff Aug 27 2015
C.R. Bard upgraded by Goldman Aug 27 2015
Bard Said to Pay $200 Million to Settle Vaginal Mesh Cases Aug 04 2015
CMS Approves Add-on Payment for Lutonix® Drug-Coated Balloon for Inpatient Use Aug 03 2015
BARD C R INC /NJ/ Financials Jul 30 2015
Thermo Fisher Scientific, Inc. Earnings Analysis: By the Numbers Jul 29 2015
Edited Transcript of BCR earnings conference call or presentation 23-Jul-15 9:00pm GMT Jul 28 2015
BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report Jul 24 2015
C.R. Bard (BCR) Beats Q2 Earnings & Revenues, Guides Up - Analyst Blog Jul 24 2015
Bard (C.R.) (BCR) Earnings Report: Q2 2015 Conference Call Transcript Jul 24 2015
C R Bard Inc Earnings Call scheduled for 5:00 pm ET today Jul 23 2015
BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2015
C.R. Bard reports 2Q loss Jul 23 2015
C.R. Bard reports 2Q loss Jul 23 2015
Bard Announces Second Quarter Results Jul 23 2015
Q2 2015 C R Bard Inc Earnings Release - After Market Close Jul 23 2015
BARD C R INC /NJ/ Files SEC form 8-K, Other Events Jul 21 2015
Can C.R. Bard (BCR) Surprise Earnings Estimates in Q2? - Analyst Blog Jul 20 2015
Steady Eddy and his stalwart blog Jul 12 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK